Table 1.
Cell of origin | Cellular/molecular target | EV-surface proteins and content | Main biological effects | References |
---|---|---|---|---|
PMN | DC/macrophage | Phosphatidylserine Annexin 1 MPO CD11b/CD18 Lactoferrin Elastase | Reduced DC phagocytosis, maturation and capacity to stimulate T-cell proliferation; reduced production of pro-inflammatory cytokines and increased release of TGF β1 by DC and macrophage (tolerogenic profile) | (23, 24) (25, 26) |
T lymphocytes | CD11b/CD18 Annexin V Elastase | Reduced release of TNFα by naive and activated effector T cells; reduced IL2 secretion and CD25 expression by resting T helper cells | (27) (28) (29) (30) (31) (32) |
|
Cytokines/membrane receptors | Catepsin G Proteinase 3 | Cleavage of cytokines and their membrane receptors | (33) (34) |
|
L-Arginine | Arginase-1 | Reduced T-cell proliferation and function | (30) | |
Neutrophil | LT B4 and enzymes for its synthesis; C5R1 | PMN chemotaxis | (35) (36) |
|
Macrophage | Macrophage and DC | p-MHC; Microbial and viral antigens; Hsp-70; IL1β; TNFα; CCL2-5; C3 fragments; Proteins of the leukotriene pathway IL 36y miR-223 | Transfer of p-MHC, antigens and activating signals to DCs; DC maturation, activation and migration; release of Th1 - (M1 macrophages- derived EVs) or Th2-promoting cytokines (M2 macrophages-derived EVs) | (37) (38) (39) (40) (41) (42) |
PMN | Enzymes of the leukotriene biosynthesis | PMN chemotaxis | (43) | |
T lymphocytes | IL1β TNFalfa and CCL2-5 proteins of the leukotriene pathway IL 36y | Increased T cell expansion and differentiation; induction of IFNy and IL 17 producing CD4+ T cells (T helper 17); inhibition of Treg | (40) (44) (45) (46) (35) (47) |
|
B lymphocytes | C3 fragments IL 36y | Increased B cell expansion and differentiation | (41, 48) (47) |
|
DC | DC | TLR4 p-MHC; Costimulatory or inhibitory molecules; miRNA (miR-148a, miR 451) | Amplification of antigen spreading among APCs and antigen presentation to T lymphocytes | (49, 50) (17, 51) (52) |
PMN | Enzymes of the leukotriene biosynthesis | Neutrophil chemotaxis | (43) | |
T lymphocytes | p-MHC; MHC II; Microbial or tumoral antigens; adhesion molecules (ICAM-1); costimulatory molecules (B7 family members) | Activation (mature DCs) or inhibition (immature DCs) of CD4/CD8 pos T lymphocytes | (4, 49) (53) (54) (55) (56) |
|
B-lymphocytes | Complement fragments, microbial or tumoral antigens | (20, 52) | ||
MC | DC | p-MHC; FcϵRI Hsp 60, Hsp 70; PLA2, PLC, PLD; PGD2,PGE2 | Transfer of p-MHC II and IgE-antigens complexes; antigens activation and DC maturation; generation of neolipid antigens | (51) (57) (58) (59) (60) (61) |
T lymphocyte | Proteases | Cytokine inactivation, T helper 2 induction | (51) | |
B lymphocyte | CD 40 | EVs binding; IL-10 competent B cells | (62) | |
Eosinophil | DC | MBP EPO | DC maturation; DC-driven Th2 response | (63) (64) |
NK | T lymphocyte | Perforin FasL | Cell lysis | (65) |